Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections

Tedizolid phosphate is an oxazolidinone antibacterial agent approved for the treatment of Gram-positive acute bacterial skin and skin structure infections (ABSSSIs) in patients aged ≥12 years. To support the use of tedizolid phosphate in adolescents with ABSSSIs, a population pharmacokinetic (PK) mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan, Sabato, Philip E., Guiastrennec, Benjamin, Ouerdani, Aziz, Feng, Hwa-Ping, Duval, Vincent, De Anda, Carisa S., Sears, Pamela S., Chou, Margaret Z., Hardalo, Catherine, Broyde, Natalya, Rizk, Matthew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597753/
https://www.ncbi.nlm.nih.gov/pubmed/34516243
http://dx.doi.org/10.1128/AAC.00895-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597753/
https://www.ncbi.nlm.nih.gov/pubmed/34516243
http://dx.doi.org/10.1128/AAC.00895-21

Ejemplares similares